PPARgamma agonist-21 (Compound 9a) is a PPARgamma agonist with an EC50 of 3.12 µM. PPARgamma agonist-21 activates PPAR-gamma to inhibit NF-kappaB and attenuate NLRP3 inflammasome assembly. PPARgamma agonist-21 blocks NLRP3-ASC and NLRP3-NEK7 interaction. PPARgamma agonist-21 attenuates the severity of gouty arthritis[1].
Molecular Weight:
433.25
Formula:
C19H17BrN2O5
Target:
NEKs,NF-kappaB,NOD-like Receptor (NLR),PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted